Bill Text: NH SB56 | 2015 | Regular Session | Chaptered
Bill Title: Establishing a commission to study oversight, regulation, and reporting of patient safety and infectious disease prevention and control issues in health care settings.
Spectrum: Bipartisan Bill
Status: (Passed) 2015-06-16 - II. Remainder Effective 06/12/15 [SB56 Detail]
Download: New_Hampshire-2015-SB56-Chaptered.html
CHAPTER 147
SB 56 – FINAL VERSION
15Apr2015… 1227h
5/21/2015 1839EBA
2015 SESSION
01/09
SENATE BILL 56
AN ACT establishing a commission to study oversight, regulation, and reporting of patient safety and infectious disease prevention and control issues in health care settings.
SPONSORS: Sen. Stiles, Dist 24; Sen. Feltes, Dist 15; Sen. Kelly, Dist 10; Sen. Bradley, Dist 3; Sen. Fuller Clark, Dist 21; Rep. Sherman, Rock 24; Rep. Rosenwald, Hills 30; Rep. McMahon, Rock 7; Rep. Emerson, Ches 11
COMMITTEE: Health and Human Services
AMENDED ANALYSIS
This bill establishes a commission to study oversight, regulation, and reporting of patient safety and infectious disease prevention and control issues in health care settings.
This bill is a request of the department of health and human services.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
15Apr2015… 1227h
5/21/2015 1839EBA
15-0378
01/09
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Fifteen
AN ACT establishing a commission to study oversight, regulation, and reporting of patient safety and infectious disease prevention and control issues in health care settings.
Be it Enacted by the Senate and House of Representatives in General Court convened:
147:1 Statement of Intent.
I. The general court recognizes that:
(a) New Hampshire is committed to improving patient safety and promoting better health care quality outcomes for its citizens.
(b) New Hampshire and its regulatory agencies are committed to working in partnership with health care providers across all health care delivery settings to identify improvement in the oversight, regulation, and reporting of patient safety and infectious disease prevention and control issues.
II. Therefore, the general court hereby establishes a commission to study oversight, regulation, and reporting of patient safety concerns as it relates to infectious disease prevention and control issues to achieve a better understanding of the landscape of credentialing and regulatory oversight of independent or private, unlicensed, and/or unaffiliated health care settings with a goal of better-informed policy decision making regarding patient safety concerns related to infectious disease control issues and a determination of the need for future remedial legislation. This commission is not intended to duplicate the work of the health care quality assurance commission under RSA 151-G but to work in collaboration regarding health care infectious disease prevention and control quality issues.
147:2 New Subdivision; Commission to Study Oversight, Regulation, and Reporting of Patient Safety and Infectious Disease Prevention and Control Issues. Amend RSA 126-A by inserting after section 67 the following new subdivision:
Commission to Study Oversight, Regulation, and Reporting of Patient Safety
and Infectious Disease Prevention and Control Issues
126-A:68 Commission to Study Oversight, Regulation, and Reporting of Patient Safety and Infectious Disease Prevention and Control Issues Established.
I. There is established a commission to study oversight, regulation, and reporting of patient safety and infectious disease prevention and control issues in health care settings.
II. The members of the commission shall be as follows:
(a) One member of the senate, appointed by the president of the senate.
(b) Three members of the house of representatives, appointed by the speaker of the house of representatives.
(c) The director of the division of public health services, department of health and human services, or designee.
(d) The bureau chief for the bureau of health facilities administration, department of health and human services, or designee.
(e) A representative of the New Hampshire board of dental examiners, appointed by the board.
(f) A representative of the New Hampshire board of medicine, appointed by the board.
(g) A representative from the New Hampshire board of nursing, appointed by the board.
(h) A representative from the New Hampshire board of pharmacy, appointed by the board.
(i) A representative from the New Hampshire board of podiatry, appointed by the board.
(j) A representative from the New Hampshire Foundation for Healthy Communities, appointed by the foundation.
(k) A representative from the New Hampshire Hospital Association, appointed by the association.
(1) A physician from the New Hampshire Medical Society, appointed by the society.
(m) A dentist from the New Hampshire Dental Society, appointed by the society.
(n) A representative from the New Hampshire Ambulatory Surgery Center Association, appointed by the association.
(o) A representative from the New Hampshire Infection Control and Epidemiology Professionals, appointed by that organization.
(p) A representative of a nursing home facility, appointed by the New Hampshire Health Care Association.
(q) Two public members, at least one of whom shall be an independent office-based health care practitioner, appointed by the governor.
(r) An APRN, appointed by the New Hampshire Nurse Practitioner Association.
III. The commission shall be an administratively attached agency, under RSA 21-G:10, to the department of health and human services.
IV. Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.
V. The commission’s study shall include, but not be limited to:
(a) Conducting an assessment of the existing framework for the oversight, regulation, and reporting of patient safety concerns related to infectious disease prevention and control issues among health care delivery settings, focused on, but not limited to, private, unlicensed, and/or unaffiliated health care settings, to help coordinate response to any arising infectious disease prevention and control concerns.
(b) Evaluating credentialing and regulatory oversight to determine unforeseen or hidden gaps which may pose barriers to timely and effective public health response to infectious disease prevention and control concerns in health care settings.
(c) Reviewing coordination of interagency communication relating to any infectious disease prevention and control concern across health care delivery settings including, but not limited to, private, unlicensed, and/or unaffiliated health care settings.
(d) Discussing potential deficits and areas for improvement in the current framework of regulatory oversight with a goal to identify recommended solutions, both legislative and non-legislative.
VI. The members of the commission shall elect a chairperson from among the members. The first meeting of the commission shall be called by the senate member. The first meeting of the commission shall be held within 60 days of the effective date of this section. Eleven members of the commission shall constitute a quorum.
VII. The commission shall report its findings and any recommendations for proposed legislation to the president of the senate, the speaker of the house of representatives, the chairperson of the health and human services oversight committee established under RSA 126-A:13, the senate clerk, the house clerk, the governor, and the state library on or before November 1, 2015.
147:3 Repeal. RSA 126-A:68, relative to a commission to study oversight, regulation, and reporting of patient safety and infectious disease prevention and control issues in health care settings, is repealed.
147:4 Effective Date.
I. Section 3 of this act shall take effect November 1, 2015.
II. The remainder of this act shall take effect upon its passage.
Approved: June 12, 2015
Effective Date: I. Section 3 shall take effect November 1, 2015.
II. Remainder shall take effect June 12, 2015.
